DrugsControl Media Services

News Detail

First Cancer TIL Therapy gets FDA Approval for Advanced Melanoma (08-03-2024)

Maryland, 8 March 2024: The U.S. Food and Drug Administration approved Amtagvi (lifileucel), the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is unable to be removed with surgery (unresectable) or has spread to ot......
View Details

Source : FDA News Release
U.S. Food and Drug Administration Amtagvi (lifileucel) skin cancer (melanoma) TIL Therapy

Related News